Azitra, Inc.
AMEX:AZTRBiotechnology
+$0.82 today
- Market cap
- $92.72M
- Beta
- -1.04
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$0.64
Volume 146.25M
Average 11.12M
AZTR Other Investing Activities
Investing cash flows not reported separately.
Azitra, Inc.AMEX: AZTR
Other Investing Activities · Q2 FY2026 · quarter ended Jun 2026
Other investing activities turns positive
Q2 FY2026 other investing activities was $0, compared with -$24.69K a year earlier. Trailing-twelve-month other investing activities was -$134.54K. Over 3 fiscal years it compounded at -19.5% a year.
Context
- Other investing activities grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other investing activities holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$33.63K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Investing Activities history
USD · from the cash flow
- Latest · FY2025
- (158.7K) USD
- Year-over-year change
- +57.2%
| Period | Period end | Other Investing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (158.7K) | +57.2% |
| FY2024 | 2024-12-31 | (370.68K) | -27.1% |
| FY2023 | 2023-12-31 | (291.72K) | +3.9% |
| FY2022 | 2022-12-31 | (303.66K) | -47.3% |
| FY2021 | 2021-12-31 | (206.14K) | — |
Other Investing Activities vs competitors
How AZTR compares with its peers on the latest reported figures
- AZTR's LTM Jun 2026 other investing activities of $134.54K is the largest of the 2 companies compared; the peer median is $0.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $134.54K | +11.3% | -19.5% | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding AZTR) | $0 | — | — | — | |
Competitors are the stored peer set for AZTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (8.94M) | (10.68M) | (11.28M) | (8.97M) | (10.96M) |
| Depreciation & Amortization | 84.77K | 405.98K | 425.55K | 448.24K | 453.14K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 306.06K | 184.47K | 151.51K | 245.05K | 62.74K |
| Change in Working Capital | 646.35K | 310.76K | (753.43K) | (441.72K) | (797.23K) |
| Accounts Receivables | 194.17K | 66.67K | 42.73K | 133.15K | (39.4K) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 282.98K | 420.75K | (68.68K) | (140.54K) | 0 |
| Other Working Capital | 169.2K | (176.66K) | (727.48K) | (434.33K) | (757.83K) |
| Other Non-Cash Items | (164.86K) | 1.43M | 4.1M | (1.47M) | 12.58K |
| Operating Cash Flow | (8.07M) | (8.35M) | (7.36M) | (10.18M) | (11.22M) |
| Capital Expenditures | (652.28K) | (341.01K) | (318.26K) | (379.25K) | (186.06K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (206.14K) | (303.66K) | (291.72K) | (370.68K) | (158.7K) |
| Investing Cash Flow | (652.28K) | (336.76K) | (318.26K) | (379.25K) | (182.91K) |
| Debt Repayment | 984.39K | 4.35M | (7.39K) | (14.6K) | (16.06K) |
| Common Stock Issued | 0 | 0 | 5.99M | 13.35M | 9.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 8.48K | (215.38K) | 0 | (18.38K) | (96.86K) |
| Financing Cash Flow | 992.86K | 4.13M | 5.98M | 13.32M | 8.92M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (7.73M) | (4.55M) | (1.7M) | 2.76M | (2.49M) |
| Free Cash Flow | (8.72M) | (8.69M) | (7.68M) | (10.56M) | (11.41M) |
Azitra, Inc.
AMEX:AZTR
Intrinsic Alpha fair value
Locked
Current Price
$1.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.